Compare DHIL & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DHIL | USNA |
|---|---|---|
| Founded | 1990 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 319.2M | 362.9M |
| IPO Year | 1995 | 1996 |
| Metric | DHIL | USNA |
|---|---|---|
| Price | $169.98 | $20.55 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $36.00 |
| AVG Volume (30 Days) | 39.3K | ★ 173.0K |
| Earning Date | 10-30-2025 | 10-22-2025 |
| Dividend Yield | ★ 3.55% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 17.21 | 0.90 |
| Revenue | $149,665,296.00 | ★ $912,670,000.00 |
| Revenue This Year | N/A | $9.87 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $9.82 | $22.73 |
| Revenue Growth | 2.65 | ★ 5.88 |
| 52 Week Low | $114.11 | $18.48 |
| 52 Week High | $171.43 | $38.32 |
| Indicator | DHIL | USNA |
|---|---|---|
| Relative Strength Index (RSI) | 83.20 | 50.39 |
| Support Level | $168.51 | $19.33 |
| Resistance Level | $170.55 | $21.11 |
| Average True Range (ATR) | 2.10 | 0.59 |
| MACD | 7.02 | 0.19 |
| Stochastic Oscillator | 97.77 | 52.53 |
Diamond Hill Investment Group Inc sponsors, markets, and provides investment advisory and related services to various U.S. and foreign clients including mutual funds, separate accounts, and private investment funds. The company's objective is to fulfill a fiduciary duty to clients and secondary objectives to achieve an adequate long-term return for shareholders. The company generates its revenue from Investment advisory and fund administration fees.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.